An enzyme that selectively S-nitrosylates proteins to regulate insulin signaling

Cell. 2023 Dec 21;186(26):5812-5825.e21. doi: 10.1016/j.cell.2023.11.009. Epub 2023 Dec 5.

Abstract

Acyl-coenzyme A (acyl-CoA) species are cofactors for numerous enzymes that acylate thousands of proteins. Here, we describe an enzyme that uses S-nitroso-CoA (SNO-CoA) as its cofactor to S-nitrosylate multiple proteins (SNO-CoA-assisted nitrosylase, SCAN). Separate domains in SCAN mediate SNO-CoA and substrate binding, allowing SCAN to selectively catalyze SNO transfer from SNO-CoA to SCAN to multiple protein targets, including the insulin receptor (INSR) and insulin receptor substrate 1 (IRS1). Insulin-stimulated S-nitrosylation of INSR/IRS1 by SCAN reduces insulin signaling physiologically, whereas increased SCAN activity in obesity causes INSR/IRS1 hypernitrosylation and insulin resistance. SCAN-deficient mice are thus protected from diabetes. In human skeletal muscle and adipose tissue, SCAN expression increases with body mass index and correlates with INSR S-nitrosylation. S-nitrosylation by SCAN/SNO-CoA thus defines a new enzyme class, a unique mode of receptor tyrosine kinase regulation, and a revised paradigm for NO function in physiology and disease.

Keywords: S-nitrosylation, nitric oxide, redox signaling, posttranslational modification, diabetes, nitrosylase, insulin receptor.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Acyl Coenzyme A / metabolism
  • Adipose Tissue / metabolism
  • Animals
  • Humans
  • Insulin Resistance
  • Insulin*
  • Mice
  • Nitric Oxide / metabolism
  • Oxidoreductases Acting on CH-CH Group Donors* / metabolism
  • Signal Transduction*

Substances

  • Acyl Coenzyme A
  • Insulin
  • Nitric Oxide
  • S-nitroso-coenzyme A
  • Oxidoreductases Acting on CH-CH Group Donors